Clinical Trial: How [14C]-DSP-5336 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Patients With Advanced Blood Cancers

U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07444268) titled 'How [14C]-DSP-5336 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Patients With Advanced Blood Cancers' on Feb. 06.

Brief Summary: The purpose of this study is to evaluate the absorption, metabolism, and excretion of DSP-5336 following a single oral administration of the study drug in patients with hematologic malignancies whose disease has progressed after available standard therapies.

Study Start Date: March 02

Study Type: INTERVENTIONAL

Condition: Advanced Hematologic Malignancies

Intervention: DRUG: DSP-5336

tablet

DRUG: [14C]-DSP-5336

oral solution

Recruitment Status: NOT_YET_RECRUITIN...